Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-002251-33-AT
EUCTR2006-002251-33-AT
Active, not recruiting
Not Applicable

Hypoxia Imaging with the novel Radiopharmaceutical 18F Fluoroazomycin Arabinoside (FAZA)- Prognostic impact in Cervical Cancer . - 18F-FAZA

niversity of Vienna0 sites25 target enrollmentOctober 30, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Vienna
Enrollment
25
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 30, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
niversity of Vienna

Eligibility Criteria

Inclusion Criteria

  • •First diagnosis of histologically proven cervical cancer FIGO stage IB2 to IVA.
  • •Treatment intention for the purpose of achieving cure
  • •Age \< 80 years
  • •No previous standard or radical hysterectomy
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Pregnancy, breast\-feeding women, patients that are not able to lie motionless for one hour.
  • •Palliative treatment, recurrent disease, neoadjuvant chemotherapy, other pre\-existing malignancies, age \> 80 years,

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
Hypoxia Imaging With 18F FAZA. Prognostic Impact in Cervical CancerUterine Cervical Neoplasms
NCT00388687Medical University of Vienna25
Active, not recruiting
Phase 1
Imaging of tumor hypoxia with [18F]HX4 PET
EUCTR2014-003873-41-NLMAASTRO Clinic100
Completed
Phase 2
on invasive imaging of tumor hypoxia with [18F]HX4 Positron-Emission-Tomography (PET): A phase II trialhersenen, primaire maligne glioom of metastasencancer: several diseases1001799010038597
NL-OMON44468MAASTRO Clinic120
Completed
Not Applicable
Hypoxia imaging in the brain and spinal cord of ALSneurological diseases
JPRN-UMIN000026862Okayama university15
Not yet recruiting
Not Applicable
hypoxic imaging for brain tumor with 18F-fluoromisonidazole PETbrain tumor
JPRN-UMIN000042213Kyoto University Graduate School of Medicine170